Daffodil Drugs Private Limited - Company Profile

It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2008.
2008 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Daffodil Drugs Private Limited

Daffodil Drugs Private Limited, a active private limited company, was established on 02 July 2008 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909WB2008PTC127083. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹6.50 M and a paid-up capital of ₹6.30 M.

It upholds a compliant status. Employing 69 professional, Its leadership includes Madhumita Majumdar (Director), Prodyot Mazumder (Director). It holds ₹12.62 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 17/4/1 Nafar Chandra Das Road P.S. Behala, Kolkata, West Bengal, 700034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909WB2008PTC127083

  • Registration Number

    127083

  • Incorporation Date

    02 July 2008

  • Authorized Capital

    ₹6.50 M

  • Paid-Up Capital

    ₹6.30 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.50 M
  • Paid Up Capital ₹ 6.30 M
  • Company Age 17 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 12.62 Cr
  • Revenue Growth **** 39.86%
  • Profit Growth **** 39.08%
  • Ebitda **** 29.36%
  • Net Worth 29.80%
  • Total Assets **** 53.49%
Company report

Daffodil Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Daffodil Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Daffodil Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Madhumita Majumdar Director 02 Jul 2008 Current
Prodyot Mazumder Director 02 Jul 2008 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Daffodil Drugs.

Daffodil Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.86% increase. The company also saw a substantial improvement in profitability, with a 39.08% increase in profit. The company's net worth Soared by an impressive increase of 29.8%.

Daffodil Drugs revenue growth over time
Daffodil Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 39.86%
*******
*******
*******
*******
Revenue from Operations
*******
 40.06%
*******
*******
*******
*******
Total Assets
*******
 53.49%
*******
*******
*******
*******
Profit or Loss
*******
 39.08%
*******
*******
*******
*******
Net Worth
*******
 29.80%
*******
*******
*******
*******
EBITDA
*******
 29.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Daffodil Drugs?

In 2022, Daffodil Drugs had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹126,170,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Indian Bank : 12.62 Cr
Latest Charge Details
Date Lender Amount Status
02 Mar 2022 Indian Bank ₹1.10 Cr Open
02 Mar 2022 Indian Bank ₹1.00 Cr Open
30 Nov 2021 Indian Bank ₹6.81 M Open
23 Sep 2020 Indian Bank ₹2.35 M Open
10 Sep 2020 Indian Bank ₹0.75 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Daffodil Drugs?

Daffodil Drugs has a workforce of 69 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Daffodil Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffodil Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Daffodil Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Daffodil Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Daffodil Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was recorded as a recent event.

  • Charges

    Progress on A charge with Indian Bank of Rs. 94.51 M registered on 15 May 2009 with Charge ID 10162803 was modified on 25 Feb 2025. was documented.

  • Charges

    Progress on A charge with Indian Bank amounted to Rs. 11.00 M with Charge ID 100542807 was registered on 02 Mar 2022. was documented.

  • Charges

    A charge with Indian Bank amounted to Rs. 10.00 M with Charge ID 100542810 was registered on 02 Mar 2022. was recorded as a recent event.

  • Charges

    Progress on A charge with Indian Bank amounted to Rs. 6.81 M with Charge ID 100519031 was registered on 30 Nov 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Daffodil Drugs Private Limited?

The CIN of Daffodil Drugs Private Limited is U51909WB2008PTC127083.

Where is Daffodil Drugs Private Limited headquartered?

Daffodil Drugs Private Limited is headquartered at 17/4/1 Nafar Chandra Das Road P.S. Behala, Kolkata, West Bengal, 700034.

When was Daffodil Drugs Private Limited incorporated?

Daffodil Drugs Private Limited was incorporated on 02 July 2008.

Who are the current directors of Daffodil Drugs Private Limited?

The current directors of Daffodil Drugs Private Limited are

What is the primary industry of Daffodil Drugs Private Limited?

The primary industry of Daffodil Drugs Private Limited is Trade.

Is Daffodil Drugs Private Limited a listed company?

Daffodil Drugs Private Limited is unlisted.

What is the capital structure of Daffodil Drugs Private Limited?

The authorized capital of Daffodil Drugs Private Limited is ₹6.50 M, and the paid-up capital is ₹6.30 M.

What is the compliance status of Daffodil Drugs Private Limited?

The compliance status of Daffodil Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available